Postgraduate Program in Dentistry, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
Department of Dentistry, Oral Pathology Section, Pontifical Catholic University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Oral Dis. 2024 May;30(4):2110-2121. doi: 10.1111/odi.14694. Epub 2023 Jul 24.
This study aimed to investigate the role of blood and lymphatic microvascular density in the progression of oral squamous cell carcinoma (OSCC).
The sample was composed of 54 cases of OSCC. The immunoexpression to anti-alpha-smooth muscle actin (α-SMA) and to anti-endoglin (CD105) was used to determine the microvessel density (MVD); anti-podoplanin (D2-40) was used to assess the lymphatic vessel density (LVD); vascular endothelial growth factor (VEGF) was evaluated in malignant cells. The histological differentiation, the worst pattern of invasion (WPOI), tumour thickness and tumour budding (TB) intensity were assessed using haematoxylin-eosin and anti-pan-cytokeratin (AE1/AE3). Patients' age and sex, TNM classification and follow-up time were collected from the medical records.
MVD markers presented a similar pattern of expression in blood vessels. However, only α-SMA + MVD was significantly higher among women and in tumours ≤4 cm. LVD was lower in tumours with lymph node metastasis. Regarding the histological parameters, high TB intensity was associated with histological differentiation, advanced clinical stage, greater tumour thickness and reduced disease-free survival. No difference was found in VEGF.
The decrease in OSCC LVD could be related to pathological node involvement, whereas high TB intensity could indicate OSCC progression and worse patient outcomes.
本研究旨在探讨血液和淋巴微血管密度在口腔鳞状细胞癌(OSCC)进展中的作用。
本样本由 54 例 OSCC 组成。采用抗α-平滑肌肌动蛋白(α-SMA)和抗内皮糖蛋白(CD105)的免疫组化方法来确定微血管密度(MVD);抗 podoplanin(D2-40)用于评估淋巴管密度(LVD);恶性细胞中评估血管内皮生长因子(VEGF)。使用苏木精-伊红和抗泛细胞角蛋白(AE1/AE3)评估组织学分化、最差浸润模式(WPOI)、肿瘤厚度和肿瘤芽(TB)强度。从病历中收集患者的年龄、性别、TNM 分类和随访时间。
MVD 标志物在血管中的表达模式相似。然而,只有α-SMA+MVD 在女性和≤4cm 的肿瘤中显著更高。有淋巴结转移的肿瘤 LVD 较低。就组织学参数而言,高 TB 强度与组织学分化、临床分期较晚、肿瘤厚度较大和无病生存率降低有关。VEGF 无差异。
OSCC LVD 的降低可能与病理性淋巴结受累有关,而高 TB 强度可能表明 OSCC 进展和患者预后较差。